Satoru Nagase - Gynecology

Author Information

Satoru Nagase is affiliated with the Department of Obstetrics and Gynecology at Yamagata University Faculty of Medicine, located at 2-2-2 Iida-nishi, Yamagata, 990-9585, Japan. His research focuses on various aspects of gynecologic oncology, including endometrial cancer, cervical cancer, and ovarian cancer.

Research Contributions

Satoru Nagase has made significant contributions to the field of gynecology, particularly in gynecologic oncology. His research spans across multiple subdomains, including the impact of glutathione synthesis on endometrial cancer, the significance of histology and nodal status in cervical cancer, and the association between hospital treatment volume and survival rates in gynecologic malignancies. His work often involves collaboration with various committees and societies such as the Japan Society of Obstetrics and Gynecology and the Japan Society of Gynecologic Oncology, contributing to annual reports and guidelines evaluation.

Aliases

The author is also known by the aliases S Nagase and S. Nagase.

Publication and Citation Metrics

Metric	Value
h-index	40
Total Citations	4931
Total Papers	204

Publications:

Impact of the glutathione synthesis pathway on sulfasalazine-treated endometrial cancer

DOI: 10.18632/oncotarget.28185

Year: 2022

Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2018 and Annual Treatment Report for 2013

DOI: 10.1111/jog.15134

Year: 2022

Significance of histology and nodal status on the survival of women with early-stage cervical cancer: validation of the 2018 FIGO cervical cancer staging system.

DOI: 10.3802/jgo.2022.33.e26

Year: 2022

Issue Information

DOI: 10.1111/jog.14842

Year: 2022

MicroRNA-152 Regulates Endometrial Serous Carcinoma Cell Motility by Suppressing Matrix Metalloproteinase 10 Expression.

DOI: 10.1620/tjem.256.249

Year: 2022

Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction study.

DOI: 10.3802/jgo.2022.33.e3

Year: 2021

Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual patient report for 2017 and annual treatment report for 2012

DOI: 10.1111/jog.14724

Year: 2021

The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines evaluation committee

DOI: 10.3802/jgo.2021.32.e44

Year: 2021

Efficacy and safety of standard of care with/without bevacizumab for platinum‐resistant ovarian/fallopian tube/peritoneal cancer previously treated with bevacizumab: The Japanese Gynecologic Oncology Group study JGOG3023

DOI: 10.1111/cas.15185

Year: 2021

Association between hospital treatment volume and survival of surgical cases with gynecologic malignancy in Japan

DOI: 10.3802/jgo.2021.32.s1.omi5

Year: 2021

What is TENS?

How are Fibrocystic Breast Changes Diagnosed?

What Are Hereditary Disorders in Gynecology?

How Can One Stay Updated with Coding Changes?

What is Included in a Gynecological Report?

What are congenital uterine abnormalities?

Can Birth Control Help Regulate My Periods?

What are Digestive Enzymes?

How does age affect gynecological needs?

How Can Women Prepare for Routine Screenings?

Partnered Content Networks

Relevant Topics